To determine vaccine acceptance and hesitancy attitudes toward coronavirus disease 2019(COVID-19) vaccines in Egyptian pregnant women.
Although 2 years passed since the Covid 19 pandemic started, no specific treatment
against the disease is available. According to WHO, more than two million deaths have
been recorded worldwide . Therefore, it is important to avoid infection. In the absence
of an effective treatment for coronavirus disease 2019 (COVID-19) non-pharmaceutical
interventions are the only available methods of disease control. Social distancing, face
masks, and personal hygiene are the most effective precautions, but maintaining these
actions is not practicable in the long term. As a result, vaccination becomes the most
effective eradication method. (1,2) Research into development of a vaccine for SARS-CoV-2
was undertaken immediately after the disease was identified.(3) The success of a vaccine
depends not only on its efficacy, but also its acceptance.
However, vaccine hesitancy has become an important threat to global health, which was
pointed out by WHO in 2019.(4) Several key factors behind vaccine hesitancy include fear
or mistrust of the vaccine, underestimation of the value of the vaccine, and lack of
access to the vaccine.(5) Pregnant women are at increased risk of severe disease, ICU
admission, and ventilation when compared with non-pregnant patients of the same age.(6-8)
Therefore, pregnant women are classified as a high-risk population for COVID-19
infection.(9) Regarding this information, pregnant women have not been included in any
COVID-19 vaccine clinical trials to date.(10) Even so, public health authorities,
including the ACOG and the SMFM recommend that COVID-19 vaccines should be available for
pregnant women if they prefer to be vaccinated.(11,12)
Inclusion Criteria:
- pregnant women at any gestational age
Exclusion Criteria:
- Covid 19 suspicious patients at time of survey.
- patients refusing survey
- obstetric emergency.
Not Provided
Not Provided